AAAAAA
Results: 1-25/34
Authors:
NIKATEGHAD F
DECKER J
CASELMANN WH
GEISSLER F
LUND P
PETMECKY K
SCHIRMACHER P
Citation: F. Nikateghad et al., GENOMIC IMBALANCES IN HUMAN HEPATOCELLULAR CARCINOMAS (HCCS), Hepatology, 28(4), 1998, pp. 61-61
Authors:
HEINICKE T
HEMMI S
MAUER D
SAUERBRUCH T
CASELMANN WH
Citation: T. Heinicke et al., EXPRESSION OF THE COXSACKIE AND ADENOVIRUS RECEPTOR DETERMINES TRANSDUCIBILITY OF COLORECTAL-CANCER CELLS, Hepatology, 28(4), 1998, pp. 1419-1419
Authors:
SAUERBRUCH T
SPENGLER U
CASELMANN WH
Citation: T. Sauerbruch et al., UNTITLED, Digestion, 59, 1998, pp. 1-1
Authors:
CASELMANN WH
Citation: Wh. Caselmann, PATHOGENESIS OF HEPATOCELLULAR-CARCINOMA, Digestion, 59, 1998, pp. 60-63
Authors:
EISENHARDT S
SAMSTAG W
JAHNHOFMAN K
ENGELS JW
RENZ R
HOFSCHNEIDER PH
CASELMANN WH
ALT M
Citation: S. Eisenhardt et al., BACKBONE MODIFIED ANTISENSE OLIGODEOXYNUCLEOTIDES DIRECTED AGAINST THE HEPATITIS-C-VIRUS (HCV)-RNA, Nucleosides & nucleotides, 16(7-9), 1997, pp. 1669-1672
Authors:
ALT M
RENZ R
HOFSCHNEIDER PH
CASELMANN WH
Citation: M. Alt et al., CORE SPECIFIC ANTISENSE PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES AS POTENT AND SPECIFIC INHIBITORS OF HEPATITIS-C VIRAL TRANSLATION, Archives of virology, 142(3), 1997, pp. 589-599
Authors:
CASELMANN WH
EISENHARDT S
ALT M
Citation: Wh. Caselmann et al., SYNTHETIC ANTISENSE OLIGODEOXYNUCLEOTIDES AS POTENTIAL-DRUGS AGAINST HEPATITIS-C, Intervirology, 40(5-6), 1997, pp. 394-399
Authors:
WEINER OH
ALT M
NOEGEL AA
CASELMANN WH
Citation: Oh. Weiner et al., FLUORESCENCE CORRELATION SPECTROSCOPY FOR RAPID AND SENSITIVE HCV RNAQUANTIFICATION, Hepatology, 26(4), 1997, pp. 49-49
Authors:
JUNGST C
GEHRKE R
SCHIRMACHER P
SCHRAMEL P
GRUTZNER U
SCHMITZ V
HOFSCHNEIDER PH
CASELMANN WH
Citation: C. Jungst et al., INCREASED OXIDATIVE DNA-DAMAGE IS DETECTABLE IN PERITUMOR TISSUE WITHINFLAMMATORY INFILTRATION OF HUMAN HEPATOCELLULAR CARCINOMAS, Hepatology, 26(4), 1997, pp. 1313-1313
NONVIRAL GENE-TRANSFER TO HEPG2 AND HELA-CELLS USING ADENOASSOCIATED VIRUS INVERTED TERMINAL REPEATS
Authors:
STEIGERWALD R
CASELMANN WH
HOFSCHNEIDER PH
ALT M
Citation: R. Steigerwald et al., NONVIRAL GENE-TRANSFER TO HEPG2 AND HELA-CELLS USING ADENOASSOCIATED VIRUS INVERTED TERMINAL REPEATS, Hepatology, 26(4), 1997, pp. 1905-1905
Authors:
DELSMANN BM
CASELMANN WH
Citation: Bm. Delsmann et Wh. Caselmann, IMAGES IN HEPATOLOGY, Journal of hepatology, 26(5), 1997, pp. 1154-1154
Authors:
CASELMANN WH
RENNER M
SCHLUTER V
HOFSCHNEIDER PH
KOSHY R
MEYER M
Citation: Wh. Caselmann et al., THE HEPATITIS-B VIRUS MHBS(T167) PROTEIN IS A PLEIOTROPIC TRANSACTIVATOR MEDIATING ITS EFFECT VIA UBIQUITOUS CELLULAR TRANSCRIPTION FACTORS, Journal of General Virology, 78, 1997, pp. 1487-1495
Authors:
CASELMANN WH
SPENGLER U
FISCHER HP
SAUERBRUCH T
Citation: Wh. Caselmann et al., LIVER-CIRRHOSIS AS PRECANCEROSIS, Der Internist, 38(10), 1997, pp. 928-936
Authors:
EISENHARDT S
SAMSTAG W
JAHNHOFMANN K
ENGELS JW
BURGELT E
RENZ R
CASELMANN WH
ALT M
Citation: S. Eisenhardt et al., COMPARISON OF THE INHIBITORY EFFECT OF DIFFERENT CHEMICALLY-MODIFIED ANTISENSE OLIGODEOXYNUCLEOTIDES ON HEPATITIS-C VIRAL GENE-EXPRESSION, Hepatology, 24(4), 1996, pp. 1078-1078
Authors:
CASELMANN WH
ALT M
Citation: Wh. Caselmann et M. Alt, HEPATITIS-C VIRUS-INFECTION AS A MAJOR RISK FACTOR FOR HEPATOCELLULAR-CARCINOMA, Journal of hepatology, 24, 1996, pp. 61-66
Authors:
ALT M
RENZ R
PAUMGARTNER G
HOFSCHNEIDER PH
CASELMANN WH
Citation: M. Alt et al., ANTISENSE PHOSPHOROTHIOATE OLIGODEOXY-NUCLEOTIDES (S-ODN) AS POTENT INHIBITORS OF HEPATITIS-C VIRUS TRANSLATION, Journal of cellular biochemistry, 1995, pp. 388-388
Authors:
GEHRKE R
REIFENBERG K
GRUTZNER U
HOFSCHNEIDER PH
CASELMANN WH
Citation: R. Gehrke et al., INCREASED 8-HYDROXY-2'-DEOXYGUANOSINE FORMATION IN LIVER-TISSUES OF HEPATITIS-B VIRUS X-TRANSGENIC MICE, Hepatology, 22(4), 1995, pp. 348-348
Authors:
GEHRKE R
SCHLUTER V
HOFSCHNEIDER PH
CASELMANN WH
Citation: R. Gehrke et al., GENERATION OF TETRACYCLIN-INDUCIBLE HELA-CELL LINES EXPRESSING HEPATITIS-B VIRUS PRES2 S TRANSACTIVATOR SEQUENCES/, Hepatology, 22(4), 1995, pp. 653-653
Authors:
ALT M
RENZ R
HOFSCHNEIDER PH
PAUMGARTNER G
CASELMANN WH
Citation: M. Alt et al., SPECIFIC-INHIBITION OF HEPATITIS-C VIRAL GENE-EXPRESSION BY ANTISENSEPHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES, Hepatology, 22(3), 1995, pp. 707-717
Authors:
ALT M
CASELMANN WH
Citation: M. Alt et Wh. Caselmann, LIVER-DIRECTED GENE-THERAPY - MOLECULAR TOOLS AND CURRENT PRECLINICALAND CLINICAL-STUDIES, Journal of hepatology, 23(6), 1995, pp. 746-758
Authors:
HANDSCHUH G
CASELMANN WH
Citation: G. Handschuh et Wh. Caselmann, BACTERIAL EXPRESSION AND PURIFICATION OF HEPATITIS-C VIRUS CAPSID PROTEINS OF DIFFERENT SIZE, Journal of hepatology, 22(2), 1995, pp. 143-150
Authors:
CASELMANN WH
Citation: Wh. Caselmann, TRANSACTIVATION OF CELLULAR GENE-EXPRESSION BY HEPATITIS-B VIRAL-PROTEINS - A POSSIBLE MOLECULAR MECHANISM OF HEPATOCARCINOGENESIS, Journal of hepatology, 22, 1995, pp. 34-37
Authors:
GRAEF E
CASELMANN WH
HOFSCHNEIDER PH
KOSHY R
Citation: E. Graef et al., ENZYMATIC-PROPERTIES OF OVEREXPRESSED HBV-MEVALONATE KINASE FUSION PROTEINS AND MEVALONATE KINASE PROTEINS IN THE HUMAN HEPATOMA-CELL LINE PLC PRF/5/, Virology, 208(2), 1995, pp. 696-703
Authors:
SCHLUTER V
MEYER M
HOFSCHNEIDER PH
KOSHY R
CASELMANN WH
Citation: V. Schluter et al., INTEGRATED HEPATITIS-B VIRUS-X AND 3' TRUNCATED PRES S-SEQUENCES DERIVED FROM HUMAN HEPATOMAS ENCODE FUNCTIONALLY ACTIVE TRANSACTIVATORS/, Oncogene, 9(11), 1994, pp. 3335-3344
Authors:
GRAEF E
CASELMANN WH
WELLS J
KOSHY R
Citation: E. Graef et al., INSERTIONAL ACTIVATION OF MEVALONATE KINASE BY HEPATITIS-B VIRUS-DNA IN A HUMAN HEPATOMA-CELL LINE, Oncogene, 9(1), 1994, pp. 81-87